missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Burixafor hydrobromide, MedChemExpress
Description
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent antagonist of CXCR4 and a well anti-angiogenic drug that is of potential value in treating choroid neovascularization. Burixafor hydrobromide (TG-0054 hydrobromide) mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction.
Specifications
Specifications
| Chemical Name or Material | Burixafor hydrobromide |
| Physical Form | Solid |
| CAS | 1191450-19-7 |
| Color | Yellow |
| Quantity | 5 mg |
| Purity Grade Notes | Research |
| Molecular Formula | C27H51N8O3P.5/2HBr |
| For Use With (Application) | COVID-19-immunoregulation |
| Synonym | TG-0054 hydrobromide |
| Solubility Information | H2O : 50 mg/mL (65.02 mM; Need ultrasonic) |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?